Transarterial chemoembolization for hepatitis B virusassociated hepatocellular carcinoma: Improved survival after concomitant treatment with nucleoside analogues

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 3, 2012, Pages 317-322.e1

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Tada, Toshifumi ^a   Sone, Yasuhiro ^a   Fujimori, Masashi ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; CISPLATIN; ENTECAVIR; EPIRUBICIN; IODINATED POPPYSEED OIL; IOPAMIDOL; LAMIVUDINE; NUCLEOSIDE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; EMULSION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84857638318     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.11.012     Document Type: Article

References (34)

1. D. Doyon, A. Mouzon, A.M. Jourde, C. Regensberg, C. Frileux L'embolisation arterielle hepatique dans les tumeurs malignes du foie Ann Radiol 17 1974 593 603
2. R. Yamada, H. Nakatsuka, K. Nakamura Transcatheter arterial embolization therapy in unresectable hepatomasexperience in 15 cases Acta Hepatol Japon 20 1979 595 603
3. H. Toyoda, T. Kumada, S. Kiriyama Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan Clin Gastroenterol Hepatol 4 2006 1170 1176 (Pubitemid 44311651)
4. D.B. Brown, J.F.H. Geschwind, M.C. Soulen Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies J Vasc Interv Radiol 20 2009 S317 S323
5. T. Kumada, S. Nakano, I. Takeda Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma Hepatology 25 1997 87 92 (Pubitemid 27014990)
6. D.Y. Lin, Y.F. Liaw, T.Y. Lee, C.M. Lai Hepatic arterial embolization in patients with resectable hepatocellular carcinomaa randomized controlled trial Gastroenterology 94 1988 453 456
7. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire A comparison of lipiodol chemoembolization and conservative treatment of unresectable hepatocellular carcinoma N Engl J Med 332 1995 1256 1261
8. J. Bruix, J.M. Llovet, A. Castells Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution Hepatology 27 1998 1578 1583 (Pubitemid 28264682)
9. G. Pelletier, M. Ducreux, F. Gay Treatment of unresectable hepatocellular carcinoma with Lipiodol chemoembolization: a multicenter randomized trial Groupe CHC J Hepatol 29 1998 129 134 (Pubitemid 28307992)
10. C.E. Ray Jr, Z.J. Haskal, J.F.H. Geschwind, B. Funaki The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration Review of 2011 J Vasc Interv Radiol 22 2011 1693 1696
11. J.M. Llovet, M.I. Real, X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739 (Pubitemid 34607087)
12. C.M. Lo, H. Ngan, W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171 (Pubitemid 34454013)
13. R. Sacco, I. Bargellini, M. Bertini Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma J Vasc Interv Radiol 22 2011 1545 1552
14. H.T. Hu, J.H. Kim, L.S. Lee Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort J Vasc Interv Radiol 22 2011 917 923
15. J.P. Villeneuve, L.D. Condreay, B. Willems Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B Hepatology 31 2000 207 210 (Pubitemid 30033708)
16. F.Y. Yao, N.M. Bass Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection J Hepatol 33 2000 301 307 (Pubitemid 30485234)
17. Y.F. Liaw, J.J.Y. Sung, W.C. Chow Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
18. T.T. Chang, Y.F. Liaw, S.S. Wu Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
19. J.H. Shim, H.C. Lee, K.M. Kim Efficacy of entecavir in treatment-nave patients with hepatitis B virus-related decompensated cirrhosis J Hepatol 52 2010 176 182
20. M. Kudo Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions Semin Liver Dis 19 1999 297 309 (Pubitemid 29488772)
21. Y. Inaba, Y. Arai, M. Kanematsu Revealing hepatic metastases from colorectal cancer: value of combined helical CT during arterial portography and CT hepatic arteriography with a unified CT and angiography system AJR Am J Roentgenol 174 2000 955 961 (Pubitemid 30179982)
22. K. Takayasu, Y. Muramatsu, T. Maeda Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates AJR Am J Roentgenol 176 2001 681 688 (Pubitemid 32181966)
23. T. Murakami, H. Oi, M. Hori Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma AJR Am J Roentgenol 169 1997 131 135 (Pubitemid 27289622)
24. N. Kokudo, M. Makuuchi Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: J-HCC guidelines J Gastroenterol 44 2009 S119 S121
25. R.N.H. Pugh, I.M. Murray-Lyon, J.L. Dawson Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
26. E.L. Kaplan, P. Meier Non parametric estimation for incomplete observation J Am Stat Assoc 53 1958 457 481
27. R. Petro, M.C. Pike Conservation of the approximation (0-E2)/E in the log rank test for survival data on tumor incidence data Biometrics 29 1973 579 584
28. D. Cox Regression models and life tables J R Stat Soc 34 1972 187 220
29. T. Kuzuya, Y. Katano, T. Kumada Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma J Gastroenterol Hepatol 22 2007 1929 1935 (Pubitemid 47525069)
30. N. Li, E.C.H. Lai, J. Shi A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection Ann Surg Oncol 17 2010 179 185
31. S.G. Lim, R. Mohammed, M.F. Yuen, J.H. Kao Prevention of hepatocellular carcinoma in hepatitis B virus infection J Gastroenterol Hepatol 24 2009 1352 1367
32. S. Kubo, H. Tanaka, S. Takemura Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus Hepatol Res 37 2007 94 100 (Pubitemid 46403823)
33. M. Chuma, S. Hige, T. Kamiyama The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma J Gastroenterol 44 2009 991 999
34. J.S.W. Wong, G.L.H. Wong, K.K.F. Tsol Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma Aliment Pharmacol Ther 33 2011 1104 1112